INTRODUCTION
As reported in the previous paper by the authors, two kinds of precursor of plasminogen activator were presented by gel filtration method, which were named proactivator A and proactivator B.1) However the former fraction did not contain plasminogen, the latter on the other hand always coexisted with plasminogen, which seemed to be difficult to separate. Therefore, a question arises that fibrinolytic activity demonstrated by adding streptokinase (SK) to proactivator B fraction (with plasminogen) might not be mediated by the activation of proactivator but caused directly by the activation of plasminogen by SK.
To resolve the question it is required that proactivator B can be obtained which was separated from plasminogen, and that fibrinolysis should be examined by using thus obtained proactivator B.
The results in this paper are to prove that fibrinolytic activity demonstrated by proactivator B fraction is also mediated by an activator converted from proactivator B as in the case of proactivator A.
MATERIALS AND METHODS

Materials:
1) Dried human plasma (Nihon Seiyaku Co., Ltd., Tokyo) was used as a material of proactivator B fraction obtained by gel filtration.
2) Fibrinogen (Fraction I, Armour Laboratory) and Thrombin (Mochida Co., Ltd., Tokyo) were used to make fibrin plate.
3) Streptokinase (SK, Varidase, Lederle Laboratories) was used to activate 25 practivator.
4) Urokinase (UK), kindly donated by Green Cross Co., Ltd., Osaka, was used to activate plasminogen. 6) Proactivator B fraction was separated from dried human plasma by gel filtration using Sephadex G-200 (AB Pharmacia, Uppsala) (see below).
7) Rabbit plasminogen fraction was obtained according to Takada et al.2) 8) Buffers. As eluant in gel filtration 0.1M Tris-HCl (pH 8.0) in 0.2M NaCl was used.
To make fibrin plate 0.18M borate saline buffer (pH 7.75) was used.
The effluent which had proactivator B were collected and used as proactivator B fraction in following experiments.
Fibrinolytic assay
Activator activity was measured by Astrup's method3) using standard fibrin plate. Proactivator activity was measured by the same method after activation by SK. Plasminogen activity was measured by the Lassen's method4) using heated fibrin plate after activation of plasminogen by UK or SK .
RESULTS
A) Destruction of plasminogen contained in proactivator B fraction by h eating.
Proactivator B fraction was obtained from dried human plasma b y the previously mentioned method, and an attempt was made to remove plasminogen activity by heating.
First proactivator B fraction (pH 8 .0) obtained by gel filtration was divided into two groups, each of which pH was adjusted at 7 .0 and 2.0 respec- Table 5 Test of Destruction of Plasminogen Using UK as employed in the previously mentioned experiment. diluted many fold with saline and the activity of each was determined by the lysed area on the standard fibrin plate.
Also in this experiment, a direct relationship between lysed area and the content of the activator was recognized.
F) Inhibitory effects of EACA and t-AMCHA against activity of the activator B.
To determine the inhibition by EACA and t-AMCHA, lysed area caused by activator B was measured on the fibrin plate containing inhibitors.6) EACA or t-AMCHA was added to fibrinogen in final ocncentration as shown in Fig. 2 in advance to the addition of thrombin. Fig. 2 indicates that activator activity was inhibited by EACA and t-AMCHA with low concentration, which is the same with the case of activator A.7) In the present paper, an attempt was made first to abolish plasminogen activity in proactivator B fraction in order to solve this difficult question.
In the experiment using UK, the authors encountered a situation which would possibly lead to the assumption of dual action of UK in fibrinolysis, such as activation on plasminogen and proactivator by the following result. That is, when measured by a standard fibrin plate, the lysis demonstrated with the mixture of UK and proactivator B freed of plasminogen was always bigger than that demonstrated by the same units of UK only (Group A and C in table 5).
As to this point, further detailed experiments have been under way.
In the experiment in the system where fibrin, plasminogen and proactivator were sufficient and constant, fibrinolytic activity was determined by the amount of SK and also by the content of the activator. The sum of proactivator B activities presented by the gel filtration pattern of fresh blood was , although containing plasminogen, always bigger than that of proactivator A activities .
That is to indicate that proactivator B and activator B are important components in fibrinolytic system in a living body. Plasminogen activating effect of activator B was inhibited by low concentrated EACA or t-AMCHA , as was in the case of activator A.7) To seek the factor in a living body which activates those proactivators in place of SK is a next important task. As to this point, the results will be reported elsewhere. 4) The activity of activator B was inhibited by EACA and t-AMCHA as similar to the case of activator A. 5) Activation mechanism of UK in plasmin system was discussed.
6) The conclusion is that proactivator B exists in human plasma as well as proactivator A. 
